To investigate whether PD-L1 was differentially expressed in different types of SCLCs, we analyzed the association of PD-L1 expression and some clinicopathological parameters including tumor location (central and peripheral), TTF-1 expression (positive and negative), and sample types (biopsy and resection). The gene discussed is TTF1; the disease is neoplasm.